Press Releases

Press Releases

January 31, 2020
New CARE Consortium study, representing the largest biomarker study on sports-related concussions (SRC) applies ultra-sensitive biomarker solution to validate serum markers as objective indicators of mild traumatic brain injury (mTBI)
January 10, 2020
Company continues remarkable growth in 2019, fueled by new product launches, the acquisition of UmanDiagnostics, further validation in ground-breaking publications and rapid adoption of digital biomarkers in neurology and oncology research
Strong revenue growth and successful early launch of new HD-X Analyzer | November 06, 2019
Billerica, Mass.
October 25, 2019
Findings by leading researchers demonstrate the promise and relevance of Simoa in vast application areas.
October 22, 2019
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that it will release its financial results for third quarter 2019